SRRK Company Profile and Key Details
Scholar Rock Holding Corporation
SRRK Stock Price Chart
Stock Price Today
Scholar Rock Holding Corporation (SRRK) stock surged +4.12%, trading at $46.73 on NASDAQ, up from the previous close of $44.88. The stock opened at $44.91, fluctuating between $44.41 and $46.81 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 150 |
| Beta | 0.48 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Scholar Rock Holding Corporation (NASDAQ: SRRK) stock price is $46.73 in the last trading session. During the trading session, SRRK stock reached the peak price of $46.81 while $44.41 was the lowest point it dropped to. The percentage change in SRRK stock occurred in the recent session was 4.12% while the dollar amount for the price change in SRRK stock was $1.85.
The NASDAQ listed SRRK is part of Biotechnology industry that operates in the broader Healthcare sector. Scholar Rock Holding Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Edward H. Myles M.B.A., MBA
Chief Financial Officer, Chief Operating Officer & Treasurer
Mr. Edward H. Myles MBA
Chief Financial Officer, Chief Operating Officer & Treasurer
Ms. Junlin Ho J.D.
Gen. Counsel & Corporation Sec.
Ms. Catherine Hu
Vice President of Investor Relations & Corporation Communications
Ms. Caryn Parlavecchio
Chief HR Officer
Ms. Erin Moore
Senior Vice President of Fin.
Mr. Ryan Iarrobino
Senior Vice President of Clinical Devel. & Operations
Dr. Jing L. Marantz M.B.A., M.D., Ph.D.
Chief Medical Officer
Ms. Tracey M. Sacco M.B.A.
Chief Commercial Officer
Dr. Jay T. Backstrom M.D., M.P.H.
Pres, Chief Executive Officer & Director
Ms. Lisa Amaya Price
Senior Vice President & Chief HR Officer
SRRK's closing price is 591.27% higher than its 52-week low of $6.76 where as its distance from 52-week high of $46.81 is -0.17%.
Number of SRRK employees currently stands at 150.
Official Website of SRRK is: https://scholarrock.com
SRRK could be contacted at phone 857 259 3860 and can also be accessed through its website. SRRK operates from 301 Binney Street, Cambridge, MA 02142, United States.
SRRK stock volume for the day was 1.51M shares. The average number of SRRK shares traded daily for last 3 months was 1.07M.
The market value of SRRK currently stands at $4.37B with its latest stock price at $46.73 and 93.61M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com